Growth Metrics

Intelligent Bio Solutions (INBS) Accumulated Expenses (2021 - 2025)

Intelligent Bio Solutions' quarterly Accumulated Expenses came in at $534990.0 in Q2 2025, up 13.98% year-on-year from $469381.0 in Q2 2024, and up 19.51% quarter-over-quarter from $447670.0 in Q1 2025.

Intelligent Bio Solutions has reported Accumulated Expenses for 5 years, with the latest figure at $534990.0 in Q2 2025.

  • For the quarter ending Q2 2025, Accumulated Expenses rose 13.98% year-over-year to $534990.0; the trailing twelve-month figure through Jun 2025 stood at $534990.0 (up 13.98% YoY), and the FY2025 full-year result was $534990.0, up 13.98% from the prior year.
  • Accumulated Expenses for Q2 2025 stood at $534990.0, up from $447670.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $660010.0 in Q1 2024, with the low at $102475.0 in Q2 2021.
  • Average Accumulated Expenses over 5 years is $344976.2, with a median of $366893.0 recorded in 2023.
  • Year-over-year, Accumulated Expenses soared 139.5% in 2022 and tumbled 32.17% in 2025.
  • Tracing INBS's Accumulated Expenses over 5 years: stood at $129212.0 in 2021, then soared by 139.5% to $309469.0 in 2022, then rose by 18.56% to $366893.0 in 2023, then climbed by 13.64% to $416929.0 in 2024, then advanced by 28.32% to $534990.0 in 2025.
  • The last three Accumulated Expenses figures came in at $534990.0 (Q2 2025), $447670.0 (Q1 2025), and $416929.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 534,990.00
Mar 31, 2025 447,670.00
Dec 31, 2024 416,929.00
Sep 30, 2024 477,517.00
Jun 30, 2024 469,381.00
Mar 31, 2024 660,010.00
Dec 31, 2023 366,893.00
Sep 30, 2023 406,964.00
Jun 30, 2023 358,942.00
Mar 31, 2023 385,724.00
Dec 31, 2022 309,469.00
Sep 30, 2022 299,686.00
Jun 30, 2022 201,332.00
Mar 31, 2022 171,263.00
Dec 31, 2021 129,212.00
Sep 30, 2021 126,139.00
Jun 30, 2021 102,475.00